http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6160329-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2008-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5439acd4b854b8b398c5e35712a89f03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dff6196fc751ebcd10cbe40695f88647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93ad8e75995919bb948af9434b12dd9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a8809570e2352a3cab8cacc1e6312b2
publicationDate 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-6160329-A2
titleOfInvention VR1 BENCIMIDAZOLIC MODULATORS
abstract and a form thereof where: the dashed lines between positions 1, 2 and 3 of Formula (I) indicate the positions of a double tautomeric bond, where when a double bond is formed between positions 1 and 2, then R3b is present and where, when a double bond is formed between positions 2 and 3, then R3a is present; p is 1 or 2; q is 0 or 1; r is 0, 1, 2 or 3; L is C1-3 alkyl, C2-3 alkenyl, C2-3 alkynyl or cyclopropyl; A1 is selected from the group consisting of phenyl, biphenyl, naphthyl, pyridinyl, quinolinyl and indole; each R1 is selected from the group consisting of hydroxy, cyano, halogen, formyl, carboxy, alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 alkylthio , C 1-6 alkylsulfonyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-4 alkyl, C 3-8 cycloalkyl-C 1-4 alkoxy, C 3-8 cycloalkyl-oxygen, amino, (C 1-6 alkyl) 1-2 amino, ( C3-8 cycloalkyl 1-2amino, (C3-8-C1-4alkyl) 1-2amino, aminocarbonyl, (C1-6 alkyl) 1-2 aminocarbonyl, C1-6 alkylcarbonylamino, C1-6 alkoxycarbonylamino, aminocarbonylamino, ( C1-6 alkyl) 1-2aminocarbonylamino, C1-6 alkylsulfonylamino, C1-6 alkylsulfinylamino, aminosulfonyl, (C1-4 alkyl) 1-2aminosulfonyl, aminosulfonylamino and (C1-6 alkyl) 1-2 aminosulfonylamino, where the alkyl is optionally substituted with C1-8 alkoxy, amino, (C1-4 alkyl) 1-2amino, C1-6 alkylcarbonylamino, C1-6 alkoxycarbonylamino, aminocarbonylamino, (C1-6 alkyl) 1-2aminocarbonylamino, C1-6 alkylsulfonylamino, alkylsulfinylamino C1-6, aminosulfonyl, (C1-4 alkyl) 1-2 aminosulfonyl, aminosulfonylamino and (C1-6 alkyl) 1-2 aminosulfonylamino, where the alkyl is optionally substituted with C1-8 alkoxy, amino, (C1-4 alkyl) 1-2 amino, C1-6 alkylcarbonylamino, C1-6 alkoxycarbonylamino, aminocarbonylamino, (C1-6 alkyl) 1-2 aminocarbonylamino, C1-6 alkylsulfonylamino, aminosulfonylamino, ...
priorityDate 2006-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457584123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407208027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072

Total number of triples: 44.